Evidence map›Paper›PMID 34519176›Full record

ArticleHepatology communications2022

Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.

Nidhi Jalan-Sakrikar, Thiago M De Assuncao, Amaia Navarro-Corcuera, Feda H Hamdan, Lorena Loarca, Lindsey A Kirkeby, Zachary T Resch, Steven P O'Hara, Brian D Juran, Konstantinos N Lazaridis and 6 more

Open access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Biomedical applications of organoids derived from the digestive system.Frontiers in cell and developmental biology · 2025
    Review
  5. Article
  6. Review
  7. The utilisation of biliary organoids for biomedical applications.Frontiers in bioengineering and biotechnology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Nidhi Jalan-SakrikarDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.ORCID 0000-0001-6795-0121
Thiago M De AssuncaoDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Amaia Navarro-CorcueraDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Feda H HamdanDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Lorena LoarcaDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Lindsey A KirkebyCenter for Regenerative Medicine, Mayo Clinic and Foundation, Rochester, MN, USA.
Zachary T ReschCenter for Regenerative Medicine, Mayo Clinic and Foundation, Rochester, MN, USA.
Steven P O'HaraDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Brian D JuranDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Konstantinos N LazaridisDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.ORCID 0000-0002-0437-681X
Charles B RosenWilliam J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic and Foundation, Rochester, MN, USA.
Julie K HeimbachWilliam J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic and Foundation, Rochester, MN, USA.
Timucin TanerWilliam J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic and Foundation, Rochester, MN, USA.ORCID 0000-0003-0641-2930
Vijay H ShahDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.ORCID 0000-0001-7620-573X
Nicholas F LaRussoDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.
Robert C HuebertDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.ORCID 0000-0002-9812-7573
Mayo Clinic · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Nicholas F. LaRusso · 2009 to 2026
$22.2M
The Pathobiology of Hepatic EpitheliaR01DK024031 · NIDDK · MAYO CLINIC ROCHESTER · PI LARUSSO, NICHOLAS F. · 1986 to 2023
$10.4M
Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exposome and genomeRC2DK118619 · NIDDK · MAYO CLINIC ROCHESTER · PI LAZARIDIS, KONSTANTINOS N · 2018 to 2022
$7.8M
Pathophysiology of Biliary DiseaseR01DK057993 · NIDDK · MAYO CLINIC ROCHESTER · PI LARUSSO, NICHOLAS F., O'HARA, STEVEN P · 2001 to 2025
$7.1M
Molecular Mechanisms of Portal HypertensionR01DK059615 · NIDDK · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H. · 2002 to 2023
$6.4M
Molecular Mechanisms of Cholestatic FibrogenesisR01DK117861 · NIDDK · MAYO CLINIC ROCHESTER · PI Robert Christian Huebert · 2019 to 2026
$2.8M
miRNA Regulation of Aquaporin 1 Modulates Vascular Remodelling during CirrhosisK08DK100575 · NIDDK · MAYO CLINIC ROCHESTER · PI HUEBERT, ROBERT CHRISTIAN · 2013 to 2017
$757k
Molecular Mechanisms of Portal HypertensionR56DK059615 · NIDDK · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H · 2007 to 2007
$378k
Epigenetic Regulation in Primary Sclerosing CholangitisR03DK113339 · NIDDK · MAYO CLINIC ROCHESTER · PI HUEBERT, ROBERT CHRISTIAN · 2018 to 2019
$159k
NIDDK NIH HHS K08 DK100575NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK024031NIDDK NIH HHS R01 DK057993NIDDK NIH HHS R01 DK059615NIDDK NIH HHS R01 DK117861NIDDK NIH HHS R03 DK113339NIDDK NIH HHS R56 DK059615NIDDK NIH HHS RC2 DK118619
6 · The paper itself

Abstract

Primary sclerosing cholangitis (PSC) is a chronic fibroinflammatory disease of the biliary tract characterized by cellular senescence and periportal fibrogenesis. Specific disease features that are cell intrinsic and either genetically or epigenetically mediated remain unclear due in part to a lack of appropriate, patient-specific, in vitro models. Recently, our group developed systems to create induced pluripotent stem cell (iPSC)-derived cholangiocytes (iDCs) and biliary epithelial organoids (cholangioids). We use these models to investigate whether PSC cholangiocytes are intrinsically predisposed to cellular senescence. Skin fibroblasts from healthy controls and subjects with PSC were reprogrammed to pluripotency, differentiated to cholangiocytes, and subsequently grown in three-dimensional matrigel-based culture to induce formation of cholangioids. RNA sequencing (RNA-seq) on iDCs showed significant differences in gene expression patterns, including enrichment of pathways associated with cell cycle, senescence, and hepatic fibrosis, that correlate with PSC. These pathways also overlapped with RNA-seq analysis on isolated cholangiocytes from subjects with PSC. Exome sequencing on the subjects with PSC revealed genetic variants of unknown significance in the genes identified in these pathways. Three-dimensional culture revealed smaller size, lack of a central lumen, and increased cellular senescence in PSC-derived cholangioids. Congruent with this, PSC-derived iDCs showed increased secretion of the extracellular matrix molecule fibronectin as well as the inflammatory cytokines interleukin-6, and chemokine (C-C motif) ligand 2. Conditioned media (CM) from PSC-derived iDCs more potently activated hepatic stellate cells compared to control CM. Conclusion: We demonstrated efficient generation of iDCs and cholangioids from patients with PSC that show disease-specific features. PSC cholangiocytes are intrinsically predisposed to cellular senescence. These features are unmasked following biliary differentiation of pluripotent stem cells and have functional consequences in epithelial organoids.

Indexed as

Cell DifferentiationCellular SenescenceAdultAgedCells, CulturedCholangitis, SclerosingCulture Media, ConditionedCytokinesFemaleFibroblastsHumansInduced Pluripotent Stem CellsMaleMiddle AgedPhenotypeSequence Analysis, RNACulture Media, ConditionedCytokines

Identifiers

PMID34519176
PMCPMC8793999
OpenAlexW3195163265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.